Innovation and strategies for pharmas, biotechs and the R&D community
Pharmacist, male, 33 years old, Regulatory Manager at GSK based in Rio de Janeiro, Brazil. Currently responsible for all Branded Generics and Generics Regulatory activities of GSK in Brazil. I have been also supporting a couple of local Business Development initiatives …more ›
Vinzenz Plorer is Vice President Operations at EMS Pharma in charge of unbranded generics business, branded generics business, hospital business and international business. EMS is the leading pharmaceutical company in Brazil with around 10% market share of the total pha…more ›
Derek Kosti is the Worldwide Biopharmaceutical Business Controller - International for Pfizer Inc. In this role, Derek is responsible for ensuring the integrity of financial reporting, enhancing the control environment and reviewing all collaborative arrangements relat…more ›
Latin America’s leading original drug discovery conference
Drug Discovery World LatAm is where regional pharmaceutical and biotech companies, technology platform providers and academic research institutions gather to discuss original drug discovery progress and technology innovation in Latin America.
Join leading drug discovery scientists from Brazil, Mexico, Argentina, Venezuela, Colombia, Chile, Peru and more as they discus target, product and technology innovation for original drug development in Latin America.
Co-located with the Biopharma LatAm Convention, this is the leading event to attend if you’re looking to identify innovative science, original drug development and exciting discovery technology within Latin America.
Come to the Drug Discovery World Congress to learn:
- How to identify regional trends in the Latin American original drug industry
- How to keep up-to-date with recent advances and scientific discoveries
- How to identify the most promising and innovative original science being developed in Latin American laboratories
- How to optimize drug discovery and development by applying appropriate technology
- How to assess and partner with innovative technology to optimize discovery and development process
- How to identify gaps in the market, new targets and new indications to develop drugs against
- How to meet international standards in the development of new drugs
Who should sponsor?
- Assay development/platforms
- High-throughput/genomic screening
- Computer Aided Drug Discovery & informatics
- Predictive biology systems
- Diagnostics/biomarker screening
What to expect in 2012:
- Creating original pharmaceuticals in a generics market
- Indication selection in Lain America
- Choosing the right format for the right indication
- Identifying and validating new targets
- Improving lead identification and optimization
- Screening strategies
- Alternatives and emerging technologies
- Driving original drug discovery in Latin America
Co-located with the Biopharma LatAm Convention:
- Pharma Trials World LatAm
- World Generics Congress LatAm
- Exhibition hall and 12+ hours of dedicated shared networking
